Clinical Trial

EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2025 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
To compare the survival rate and improvement in stage of hypoxic ischemic encephalopathy (HIE) at day 7 of treatment in neonates treated with versus without melatonin in addition to standard supportive therapy.
Trial Details
NCT Number NCT07305350
Lead Sponsor University of Child Health Sciences and Children's Hospital, Lahore
Conditions Hypoxic Ischaemic Encephalopathy (HIE)
Enrollment 110 participants
Start Date 2025-12-10
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-05-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-26